Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | COPD Exacerbation | Research

Renaming COPD exacerbations: the UK respiratory nursing perspective

Authors: Christine Mwasuku, Joanne King, Richard E. K. Russell, Mona Bafadhel

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Patients with COPD experience acute worsenings, termed ‘exacerbations’. While other terms to describe these events have been proposed there is no consensus on terminology which has led to multiple terms being used across the UK. Respiratory nurses are part of a multi-disciplinary team managing COPD patients, however, the nursing perspective on the term ‘exacerbation’ is unknown.

Methods

An anonymised survey of 17 questions was sent to respiratory nurses through an email invitation link. The survey link was open for one month. The aim was to understand the nurse perspective on ‘exacerbation’. Alternative terms used in the UK were compared versus the term 'exacerbation’.

Results

Responses were received from 113 nurses. The majority (88%) were female. There was no consensus on preference or meaning for the term ‘exacerbation’ between nurses. Less than 5% of nurses thought that patients with COPD would understand the term ‘exacerbation’. In ranked order, the nurses preferred the following terms: ‘flare-up’, ‘lung attack’, ‘crisis’, ‘exacerbation’ and ‘chest infection’. The term ‘crisis’, although new, was considered to be the term that most resonated with clinical practice.

Conclusion

Respiratory nurses in the UK report that the term ‘exacerbation’ is not fit for purpose for patients, and alternatives should be sought.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Kessler R, Ståhl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations. Chest. 2006;130:133–42.CrossRef Kessler R, Ståhl E, Vogelmeier C, et al. Patient understanding, detection, and experience of COPD exacerbations. Chest. 2006;130:133–42.CrossRef
3.
go back to reference Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life. JAMA. 2003;66:215.CrossRef Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life. JAMA. 2003;66:215.CrossRef
6.
go back to reference Bafadhel M, Criner G, Dransfield MT, et al. Exacerbations of chronic obstructive pulmonary disease: time to rename. Lancet Respir Med. 2020;8:133–5.CrossRef Bafadhel M, Criner G, Dransfield MT, et al. Exacerbations of chronic obstructive pulmonary disease: time to rename. Lancet Respir Med. 2020;8:133–5.CrossRef
8.
go back to reference Sandelowski M. Qualitative analysis: what it is and how to begin. Res Nurs Health. 1995;18:371–5.CrossRef Sandelowski M. Qualitative analysis: what it is and how to begin. Res Nurs Health. 1995;18:371–5.CrossRef
9.
go back to reference Holverda S, Rutgers MR, Kerstjens HAM. Time to rename COPD exacerbations: implementing the term lung attack. Lancet Respir Med. 2020;8(4):25.CrossRef Holverda S, Rutgers MR, Kerstjens HAM. Time to rename COPD exacerbations: implementing the term lung attack. Lancet Respir Med. 2020;8(4):25.CrossRef
10.
go back to reference Cody WK. Paternalism in nursing and healthcare: central issues and their relation to theory. Nurs Sci Q. 2003;16:288–96.CrossRef Cody WK. Paternalism in nursing and healthcare: central issues and their relation to theory. Nurs Sci Q. 2003;16:288–96.CrossRef
11.
go back to reference NICE. Chronic obstructive pulmonary disease in over 16s: diagnosis and management NICE guideline Your responsibility Your responsibility. www.nice.org.uk/guidance/ng115. Date last updated: January 2021. Accessed 22 Jan 2021. NICE. Chronic obstructive pulmonary disease in over 16s: diagnosis and management NICE guideline Your responsibility Your responsibility. www.​nice.​org.​uk/​guidance/​ng115. Date last updated: January 2021. Accessed 22 Jan 2021.
12.
go back to reference GOLD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. www.goldcopd.org. Date last updated: 2021. Accessed 22 Jan 2021. GOLD. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. www.​goldcopd.​org. Date last updated: 2021. Accessed 22 Jan 2021.
13.
go back to reference Fletcher MJ, Dahl BH. Expanding nurse practice in COPD: Is it key to providing high quality, effective and safe patient care? Prim Care Respir J. 2013;22:230–3.CrossRef Fletcher MJ, Dahl BH. Expanding nurse practice in COPD: Is it key to providing high quality, effective and safe patient care? Prim Care Respir J. 2013;22:230–3.CrossRef
15.
go back to reference Jones KA, Gibson PG, Yorke J, et al. Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma. J Asthma. 2019;16:1–10. Jones KA, Gibson PG, Yorke J, et al. Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma. J Asthma. 2019;16:1–10.
16.
go back to reference Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J. 2018;52(5):66.CrossRef Kim V, Aaron SD. What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement. Eur Respir J. 2018;52(5):66.CrossRef
18.
go back to reference Karayama M, Inui N, Yasui H, Kono M, Hozumi H, Suzuki Y, et al. Physiological and morphological differences of airways between COPD and asthma–COPD overlap. Sci Rep. 2019;9:7818.CrossRef Karayama M, Inui N, Yasui H, Kono M, Hozumi H, Suzuki Y, et al. Physiological and morphological differences of airways between COPD and asthma–COPD overlap. Sci Rep. 2019;9:7818.CrossRef
19.
go back to reference García-Sanz MT, Cánive-Gómez JC, Senín-Rial L, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis. 2017;9:636–45.CrossRef García-Sanz MT, Cánive-Gómez JC, Senín-Rial L, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis. 2017;9:636–45.CrossRef
20.
go back to reference Flynn D, Moloney E, Bhattarai N, et al. COVID-19 pandemic in the United Kingdom. Heal Policy Technol. 2020;12:49. Flynn D, Moloney E, Bhattarai N, et al. COVID-19 pandemic in the United Kingdom. Heal Policy Technol. 2020;12:49.
22.
go back to reference Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154:959–67.CrossRef Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med. 1996;154:959–67.CrossRef
24.
go back to reference Bourbeau J, Ford G, Zackon H, et al. Impact on patients’ health status following early identification of a COPD exacerbation. Eur Respir J. 2007;30:907–13.CrossRef Bourbeau J, Ford G, Zackon H, et al. Impact on patients’ health status following early identification of a COPD exacerbation. Eur Respir J. 2007;30:907–13.CrossRef
25.
go back to reference Baker E, Fatoye F. Clinical and cost effectiveness of nurse-led self-management interventions for patients with copd in primary care: a systematic review. Int J Nurs Stud. 2017;71:125–38.CrossRef Baker E, Fatoye F. Clinical and cost effectiveness of nurse-led self-management interventions for patients with copd in primary care: a systematic review. Int J Nurs Stud. 2017;71:125–38.CrossRef
Metadata
Title
Renaming COPD exacerbations: the UK respiratory nursing perspective
Authors
Christine Mwasuku
Joanne King
Richard E. K. Russell
Mona Bafadhel
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01662-9

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.